Abstract
Cathepsin K deficiency in humans causes pycnodysostosis, which is characterized by dwarfism and osteosclerosis. Earlier studies of 10-week-old male cathepsin K-deficient (knockout, KO) mice showed their bones were mechanically more brittle, while histomorphometry showed that both osteoclasts and osteoblasts had impaired activity relative to the wild type (WT). Here, we report detailed mineral and matrix analyses of the tibia of these animals based on Fourier transform infrared microspectroscopy and imaging. At 10 weeks, there was significant hypercalcification of the calcified cartilage and cortices in the KO. Carbonate content was elevated in the KO calcified cartilage as well as cortical and cancellous bone areas. These data suggest that cathepsin K does not affect mineral deposition but has a significant effect on mineralized tissue remodeling. Since growth plate abnormalities were extensive despite reported low levels of cathepsin K expression in the calcified cartilage, we used a differentiating chick limb-bud mesenchymal cell system that mimics endochondral ossification but does not contain osteoclasts, to show that cathepsin K inhibition during initial stages of mineral deposition retards the mineralization process while general inhibition of cathepsins can increase mineralization. These data suggest that the hypercalcification of the cathepsin K-deficient growth plate is due to persistence of calcified cartilage and point to a role of cathepsin K in bone tissue development as well as skeletal remodeling.
Similar content being viewed by others
References
Dodds RA, Connor JR, Drake F, Feild J, Gowen M (1998) Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J Bone Miner Res 13:673–682
Hollberg K, Nordahl J, Hultenby K, Mengarelli-Widholm S, Andersson G, Reinholt FP (2005) Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts. J Bone Miner Metab 23:441–449
Söderstrom M, Salminen H, Glumoff V, Kirschke H, Aro H, Vuorio E (1999) Cathepsin expression during skeletal development. Biochim Biophys Acta 1446:35–46
Sondergaard BC, Henriksen K, Wulf H, Oestergaard S, Schurigt U, Brauer R, Danielsen I, Christiansen C, Qvist P, Karsdal MA (2006) Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 14:738–748
Haeckel C, Krueger S, Buehling F, Broemme D, Franke K, Schuetze A, Roese I, Roessner A (1999) Expression of cathepsin K in the human embryo and fetus. Dev Dyn 216:89–95
Buhling F, Peitz U, Kruger S, Kuster D, Vieth M, Gebert I, Roessner A, Weber E, Malfertheiner P, Wex T (2004) Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa. Biol Chem 385:439–445
Lindeman JH, Hanemaaijer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D, Verheijen JH, Hogendoorn PC (2004) Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol 165:593–600
Rapa I, Volante M, Cappia S, Rosas R, Scagliotti GV, Papotti M (2006) Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol 125:847–854
Hou WS, Li Z, Buttner FH, Bartnik E, Bromme D (2003) Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 384:891–897
Fujita Y, Nakata K, Yasui N, Matsui Y, Kataoka E, Hiroshima K, Shiba RI, Ochi T (2000) Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab 85:425–431
Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K (2004) Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538–1547
Gelb BD, Moissoglu K, Zhang J, Martignetti JA, Bromme D, Desnick RJ (1996) Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. Biochem Mol Med 59:200–206
Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453–13458
Gowen M, Lazner F, Dodds R, Kapadia R, Field J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner 14:1654–1663
Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Bromme D, Gelb BD, Beertsen W (2003) Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73:380–386
Li CY, Jepsen KJ, Majeska RJ, Zhang J, Ni R, Gelb BD, Schaffler MB (2006) Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 21:865–875
Vanderschueren D, Bouillon R (1995) Androgens and bone. Calcif Tissue Int 56:341–346
Tosi LL, Boyan BD, Boskey AL (2005) Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am 87:1631–1647
Boskey AL, Moore DJ, Amling M, Canalis E, Delany AM (2003) Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 18:1005–1011
Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD (2002) Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71:145–154
Faibish D, Gomes A, Boivin G, Binderman I, Boskey A (2005) Infrared imaging of calcified tissue in bone biopsies from adults with osteomalacia. Bone 36:6–12
Huang RY, Miller LM, Carlson CS, Chance MR (2002) Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. Bone 30:492–497
Boskey AL, Mendelsohn R (2005) Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc 38:107–114
Hamburger V, Hamilton HL (1951) A series of normal stages in the development of the chick embryo. J Morphol 88:49–92
Wang D, Pechar M, Li W, Kopecková P, Brömme D, Kopecek J (2002) Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors. Biochemistry 41:8849–8859
Lecaille F, Chowdhury S, Purisma E, Bromme D, Lalmanach G (2007) The S2 subsites of cathepsins K and L and their contribution to collagen degradation. Protein Sci 16:662–670
Demuth HU, Schierhorn A, Bryan P, Höfke R, Kirschke H, Brömme D (1996) N-Peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases. Biochim Biophys Acta 1295:179–186
Bromme D, Demuth H-U (1994) N, O-Diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases. Methods Enzymol 244:671–685
Kim YJ, Sah RLY, Doong JYH, Grodzinsky AJ (1988) Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174:168–176
Pourmand EP, Binderman I, Doty SB, Kudryashov V, Boskey AL (2006) Chondrocyte apoptosis is not essential for cartilage calcification: evidence from an in vitro avian model. J Cell Biochem 100:43–57
Boskey AL, Stiner D, Binderman I, Doty SB (1997) Effects of proteoglycan modification on mineral formation in a differentiating chick limb-bud mesenchymal cell culture system. J Cell Biochem 64:632–643
Boskey AL, Stiner D, Binderman I, Doty SB (2000) Type I collagen influences cartilage calcification: an immunoblocking study in differentiating chick limb-bud mesenchymal cell cultures. J Cell Biochem 79:89–102
Boskey AL, Stiner D, Doty SB, Binderman I, Leboy P (1992) Studies of mineralization in tissue culture: optimal conditions for cartilage calcification. Bone Miner 16:11–36
Boskey A (2003) Mineral changes in osteopetrosis. Crit Rev Eukaryot Gene Expr 13:109–116
Boskey AL, Marks SC Jr (1985) Mineral and matrix alterations in the bones of incisors-absent (ia/ia) osteopetrotic rats. Calcif Tissue Int 37:287–292
Boskey A (2007) Osteoporosis and osteopetrosis. In: Baeuerlein E, Behrens P, Epple M (eds) Biomineralization in medicine, vol 3. Handbook of biomineralization. Wiley VCH, New York, pp 59–75
Chiusaroli R, Sanjay A, Henriksen K, Engsig MT, Horne WC, Gu H, Baron R (2003) Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol 261:537–547
Hoshi K, Komori T, Ozawa H (1999) Morphological characterization of skeletal cells in Cbfa1-deficient mice. Bone 25:639–651
Rantakokko J, Aro HT, Savontaus M, Vuorio E (1996) Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393:307–313
Tarnowski CP, Ignelzi MA Jr, Morris MD (2002) Mineralization of developing mouse calvaria as revealed by Raman microspectroscopy. J Bone Miner Res 17:1118–1126
Mello MA, Tuan RS (2006) Effects of TGF-beta1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res 24:2095–2105
James IE, Lark MW, Zembryki D, Lee-Rykaczewski EV, Hwang SM, Tomaszek TA, Belfiore P, Gowen M (1999) Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents. J Bone Miner Res 14:1562–1569
Boskey AL, Maresca M, Armstrong AL, Ehrlich MG (1992) Treatment of proteoglycan aggregates with physeal enzymes reduces their ability to inhibit hydroxyapatite proliferation in a gelatin gel. J Orthop Res 10:313–319
Boskey AL, Spevak L, Doty SB, Rosenberg L (1997) Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 61:298–305
Hunter GK (1991) Role of proteoglycan in the provisional calcification of cartilage. A review and reinterpretation. Clin Orthop Relat Res 262:256–280
Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E (2005) Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36:159–172
Ling Y, Rios HF, Myers ER, Lu Y, Feng JQ, Boskey AL (2005) DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res 20:2169–2177
Acknowledgments
This study was supported by National Institutes of Health grants AR037661, AR046121, and AR41210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boskey, A.L., Gelb, B.D., Pourmand, E. et al. Ablation of Cathepsin K Activity in the Young Mouse Causes Hypermineralization of Long Bone and Growth Plates. Calcif Tissue Int 84, 229–239 (2009). https://doi.org/10.1007/s00223-008-9214-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-008-9214-6